18-19 June 2024

Board Meeting 44

Global Health Campus Geneva, Switzerland

Resolutions:

R11 - Extension of invitation to Japan to occupy the Temporary Executive Board Seat
R10 - Extension of appointment of the Members of the Policy and Strategy Committee and the Finance and Accountability Committee
R9 - Extension of appointment of the Chairs and Vice-Chairs of the Policy and Strategy Committee and the Finance and Accountability Committee
R8 - Amendments to the Code of Ethical Conduct for Unitaid Board Constituencies and Governance Officials
R7 - Audited Financial Statements for 2023 and Report of the External Auditor
R6 - Area for Intervention “Regional Manufacturing for Equitable Access” (RMEA}
R5 - Area for Intervention “Improving people-centred care through integrated diagnostic tools and delivery approaches”
R4 - Area for Intervention “Improving access to innovations in sustainable oxygen production, distribution and supply”
R3 - Area for Intervention “Improving risk detection and management of pre-eclampsia”
R2 - Area for Intervention “Improving access to care for moderate and severe anaemia in vulnerable groups in LMICs”
R1 - Functional Review

Documents:

Provisional Agenda
Minutes from the 43rd meeting of the Executive Board
Report from the Executive Director
2023-2027 Strategy – Key Performance Indicator report (June 2024)
Area for Intervention: Improving access to care for moderate and severe anaemia in vulnerable groups in LMICs
Area for Intervention: Improving risk detection and management of pre-eclampsia
Area for Intervention: Improving access to innovations in sustainable oxygen production, distribution, and supply
Area for Intervention: Improving people-centered care through integrated diagnostic tools and delivery approaches
Area for Intervention: Regional Manufacturing for Equitable Access (RMEA)
Audited financial statements 2023
Report of the external auditor 2023
Code of Ethical Conduct for Unitaid Board Constituencies and Governance Officials